|
MechanismCTAA16.88 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc. |
First Approval Date25 Sep 1998 |
100 Clinical Results associated with CTAA16.88
100 Translational Medicine associated with CTAA16.88
0 Patents (Medical) associated with CTAA16.88